Purchase our women’s health module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
Half of the worldwide population is female. The vast majority of them will benefit from drugs that belong to the women’s health category, whether it is for birth control, management of menopausal symptoms or gender-specific diseases. This makes women’s health one of the largest markets in volume.
One of the biggest challenges in women’s health will continue to be securing greater access to treatment for every woman, as cultural discrimination continues. Improvements in life expectancy around the world will be an important driver for market growth. This is especially true for drugs that target post-menopausal symptoms, seeing as women are now living longer after the menopause.
GlobalData's therapy module includes coverage of diseases such as PCOS and endometriosis.